BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18359184)

  • 1. Investigations of the cytotoxicity of epigallocatechin-3-gallate against PC-3 cells in the presence of Cd2+ in vitro.
    Zhang LC; Yu HN; Sun SL; Yang JG; He GQ; Ruan H; Shen SR
    Toxicol In Vitro; 2008 Jun; 22(4):953-60. PubMed ID: 18359184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of free Zn(2+) enhancing inhibitory effects of EGCG on the growth of PC-3 cells: interactions with mitochondria.
    Yang J; Yu H; Sun S; Zhang L; Das UN; Ruan H; He G; Shen S
    Biol Trace Elem Res; 2009 Dec; 131(3):298-310. PubMed ID: 19326061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of laminin tyrosine-isoleucine-glycine-serine-arginine peptide on the growth of human prostate cancer (PC-3) cells in vitro.
    Yu HN; Zhang LC; Yang JG; Das UN; Shen SR
    Eur J Pharmacol; 2009 Aug; 616(1-3):251-5. PubMed ID: 19577562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death.
    Basu A; Haldar S
    Int J Oncol; 2009 Jan; 34(1):281-6. PubMed ID: 19082499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
    Stuart EC; Scandlyn MJ; Rosengren RJ
    Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G.
    Lee JH; Jeong YJ; Lee SW; Kim D; Oh SJ; Lim HS; Oh HK; Kim SH; Kim WJ; Jung JY
    Cancer Lett; 2010 Apr; 290(1):68-75. PubMed ID: 19781850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway.
    Wu PP; Kuo SC; Huang WW; Yang JS; Lai KC; Chen HJ; Lin KL; Chiu YJ; Huang LJ; Chung JG
    Anticancer Res; 2009 Apr; 29(4):1435-42. PubMed ID: 19414399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis by epigallocatechin-3-gallate via mitochondrial signal transduction pathway.
    Zhao Y; Yang LF; Ye M; Gu HH; Cao Y
    Prev Med; 2004 Dec; 39(6):1172-9. PubMed ID: 15539052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells.
    Hsuuw YD; Chan WH
    Ann N Y Acad Sci; 2007 Jan; 1095():428-40. PubMed ID: 17404055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free Zn(2+) enhances inhibitory effects of EGCG on the growth of PC-3 cells.
    Sun SL; He GQ; Yu HN; Yang JG; Borthakur D; Zhang LC; Shen SR; Das UN
    Mol Nutr Food Res; 2008 Apr; 52(4):465-71. PubMed ID: 18324707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
    Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
    J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
    Ho YC; Yang SF; Peng CY; Chou MY; Chang YC
    J Oral Pathol Med; 2007 Nov; 36(10):588-93. PubMed ID: 17944751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
    Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
    Suganuma M; Okabe S; Kai Y; Sueoka N; Sueoka E; Fujiki H
    Cancer Res; 1999 Jan; 59(1):44-7. PubMed ID: 9892181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interactions of EGCG and Cd(2+) on the growth of PC-3 cells and their mechanisms.
    Yu HN; Shen SR; Yin JJ
    Food Chem Toxicol; 2007 Feb; 45(2):244-9. PubMed ID: 17046135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
    Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia.
    Iwasaki R; Ito K; Ishida T; Hamanoue M; Adachi S; Watanabe T; Sato Y
    Cancer Sci; 2009 Feb; 100(2):349-56. PubMed ID: 19200260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.